A Cork-based firm, led by Dr Sinéad Bleiel, is trying to adapt its encapsulation technology to deliver vaccines in partnership with Poolbeg Pharm
The biggest challenge for any medical research scientist is to translate their work into products that can be used to treat real-world conditions says Dr Sinéad Bleiel.
The founder of AnaBio Technologies – a firm that specialises in the process of micro-encapsulation in which active medical or other particles can be surrounded by a coating to create small capsules – has worked “to bridge the gap between the lab and the pilot plant, and commercialisation” in 11 years since starting the Cork-based firm.
Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost effectively than the traditional biotech model.
